Company Shares of Vascular Biogenics Ltd. (NASDAQ:VBLT) Drops by -6.98%

Company Shares of Vascular Biogenics Ltd. (NASDAQ:VBLT) Drops by -6.98%

Its clinical pipeline is based on two platform technologies that leverage the bodys natural physiologic and genetic regulatory elements. As of June 6, 2014, it has developed two programs based on these platforms an oncology program and an anti

(Visited 1 times, 1 visits today)
5
Like
Save

Comments

Comments are disabled for this post.